Phase 2 Cardiomyopathy Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been clinically diagnosed with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes abnormally thick, in line with recognised medical guidelines
• People whose specific type of HCM (non-obstructive HCM) has been confirmed through ultrasound heart scans done at rest and during exercise, reviewed by a specialist imaging laboratory
• People whose heart condition affects their daily activities at a moderate level, classified as Class II or III on a standard scale used by doctors to measure heart-related limitations
• People who show a measurable reduction in physical ability, confirmed through a specialised exercise breathing test done during screening

Who may not be able to join:

• People whose thickened heart muscle is caused by a known or suspected underlying condition such as a storage disorder or infiltrative disease, rather than non-obstructive HCM
• People who have another condition that the trial doctor considers to be the main cause of their breathlessness, difficulty exercising, or chest pain
• People who are unable to exercise on a treadmill or stationary bicycle, for example due to joint or movement problems
• People who have a medical condition that prevents them from safely doing an upright exercise stress test

Other eligibility criteria set out in the trial protocol also apply, and the trial site will assess these during screening.

Important: Always verify eligibility with the trial site directly before applying.